-
1
-
-
0001690740
-
Hemorrhagic diathesis with prolonged coagulation time associated with a circulating anticoagulant
-
E.L. Lozier, L.S. Jolliffe, and F.H.L. Taylor Hemorrhagic diathesis with prolonged coagulation time associated with a circulating anticoagulant Am. J. Med. Sci. 199 1940 318 327
-
(1940)
Am. J. Med. Sci.
, vol.199
, pp. 318-327
-
-
Lozier, E.L.1
Jolliffe, L.S.2
Taylor, F.H.L.3
-
2
-
-
85047693150
-
A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy
-
R. Lottenberg, T.B. Kentro, and C.S. Kitchens A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy Arch. Intern. Med. 147 1987 1077 1081
-
(1987)
Arch. Intern. Med.
, vol.147
, pp. 1077-1081
-
-
Lottenberg, R.1
Kentro, T.B.2
Kitchens, C.S.3
-
3
-
-
0034808836
-
L'h́mophilie acquise:: Approches diagnostiques et th́rapeutiques actuelles
-
H. Ĺvesque, J.Y. Borg, P. Bossi, J. Goudemand, B. Guillet, and J. Cabane L'h́mophilie acquise:: approches diagnostiques et th́rapeutiques actuelles Rev. Med. Interne 22 2001 854 866
-
(2001)
Rev. Med. Interne
, vol.22
, pp. 854-866
-
-
Ĺvesque, H.1
Borg, J.Y.2
Bossi, P.3
Goudemand, J.4
Guillet, B.5
Cabane, J.6
-
4
-
-
0001242335
-
An acquired haemorrhagicdisease in a female due to an inhibitor of blood coagulation
-
P. Fantl, and M.H. Nance An acquired haemorrhagicdisease in a female due to an inhibitor of blood coagulation Med. J. Austr. 2 1946 125 129
-
(1946)
Med. J. Austr.
, vol.2
, pp. 125-129
-
-
Fantl, P.1
Nance, M.H.2
-
5
-
-
0006895933
-
Haemorrhagic diathesis associated with low thromboplastic activity and circulating anticoagulant
-
R.W. Heinle, A.S. Weisberger, and P.J. Vignos Haemorrhagic diathesis associated with low thromboplastic activity and circulating anticoagulant J. Lab. Clin. Med. 34 1949 1606 1610
-
(1949)
J. Lab. Clin. Med.
, vol.34
, pp. 1606-1610
-
-
Heinle, R.W.1
Weisberger, A.S.2
Vignos, P.J.3
-
6
-
-
0029948962
-
Combinated treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitors
-
M. Jose-Aguado, V. Carrasco, A. Periago, T. Bello, E. Gonzalez, and J. Garcia-Talavera Combinated treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitors Sangre (Barc.) 41 1996 147 150
-
(1996)
Sangre (Barc.)
, vol.41
, pp. 147-150
-
-
Jose-Aguado, M.1
Carrasco, V.2
Periago, A.3
Bello, T.4
Gonzalez, E.5
Garcia-Talavera, J.6
-
8
-
-
0030700329
-
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa
-
C.R.M. Hay, C. Negrier, and C.A. Ludlam The treatment of bleeding in acquired haemophilia with recombinant factor VIIa Thromb. Haemost. 78 1997 1463 1467
-
(1997)
Thromb. Haemost.
, vol.78
, pp. 1463-1467
-
-
Hay, C.R.M.1
Negrier, C.2
Ludlam, C.A.3
-
9
-
-
0019501541
-
A survey of 215 non-hemophilic patients with inhibitors to factor VIII
-
D. Green, and K. Lechner A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb. Haemost. 45 1981 200 203
-
(1981)
Thromb. Haemost.
, vol.45
, pp. 200-203
-
-
Green, D.1
Lechner, K.2
-
10
-
-
0032213540
-
Acquired hemophilia due to factor VIII inhibitors in 34 patients
-
P. Bossi, J. Cabane, J. Ninet, R. Dhote, T. Hanslik, and O. Chosidow Acquired hemophilia due to factor VIII inhibitors in 34 patients Am. J. Med. 105 1998 400 408
-
(1998)
Am. J. Med.
, vol.105
, pp. 400-408
-
-
Bossi, P.1
Cabane, J.2
Ninet, J.3
Dhote, R.4
Hanslik, T.5
Chosidow, O.6
-
11
-
-
0027379905
-
A prospective randomised trial of prednisolone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies
-
D. Green, A.W. Rademaker, and E. Briet A prospective randomised trial of prednisolone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies Thromb. Haemost. 70 1993 753 757
-
(1993)
Thromb. Haemost.
, vol.70
, pp. 753-757
-
-
Green, D.1
Rademaker, A.W.2
Briet, E.3
-
12
-
-
0019426520
-
Corticosteroid therapy for acquired factor VIII: C inhibitors
-
J.A. Spero, J.H. Lewis, and U. Hasiba Corticosteroid therapy for acquired factor VIII: C inhibitors Br. J. Haematol. 48 1981 635 642
-
(1981)
Br. J. Haematol.
, vol.48
, pp. 635-642
-
-
Spero, J.A.1
Lewis, J.H.2
Hasiba, U.3
-
13
-
-
0029998402
-
Recommendations for the treatment of factor VIII inhibitors: From the UK Haemophilia Centre Directors Organisation Inhibitor Working Party
-
C.R. Hay, B.T. Colvin, C.A. Ludlam, F.G. Hill, and F.E. Preston Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors Organisation Inhibitor Working Party Blood Coagul. Fibrinolysis 7 1996 134 138
-
(1996)
Blood Coagul. Fibrinolysis
, vol.7
, pp. 134-138
-
-
Hay, C.R.1
Colvin, B.T.2
Ludlam, C.A.3
Hill, F.G.4
Preston, F.E.5
-
14
-
-
0027405692
-
Use of porcine factor VII in the treatment of patients with acquired hemophilia
-
A.E. Morrison, C.A. Ludlam, and C. Kessler Use of porcine factor VII in the treatment of patients with acquired hemophilia Blood 81 1993 1513 1520
-
(1993)
Blood
, vol.81
, pp. 1513-1520
-
-
Morrison, A.E.1
Ludlam, C.A.2
Kessler, C.3
-
15
-
-
0027285439
-
Comparison of anti-human an anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. a French Multicentric Study
-
M. Fiks-Sigaud, L. Bendelac, A. Parquet, F. Verroust, M.F. Torchet, and A.M. Berthier Comparison of anti-human an anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study Vox Sang. 64 1993 210 214
-
(1993)
Vox Sang.
, vol.64
, pp. 210-214
-
-
Fiks-Sigaud, M.1
Bendelac, L.2
Parquet, A.3
Verroust, F.4
Torchet, M.F.5
Berthier, A.M.6
-
16
-
-
0021368359
-
Clinical experience with polyelctrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII
-
P.B. Kernoff, N.D. Thomas, P.A. Lilley, K.B. Matthews, and E.G. Goldman Etuddenham Clinical experience with polyelctrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII Blood 63 1984 31 41
-
(1984)
Blood
, vol.63
, pp. 31-41
-
-
Kernoff, P.B.1
Thomas, N.D.2
Lilley, P.A.3
Matthews, K.B.4
Goldman Etuddenham, E.G.5
-
17
-
-
0032140169
-
Le facteur VII recombinant activ́:: Un nouveau traitement de l'h́mophilie
-
J. Goudeman Le facteur VII recombinant activ́:: un nouveau traitement de l'h́mophilie Transfus. Clin. Biol. 5 1998 260 265
-
(1998)
Transfus. Clin. Biol.
, vol.5
, pp. 260-265
-
-
Goudeman, J.1
-
18
-
-
0030700329
-
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa
-
C.R.M. Hay, C. Negrier, and C.A. Ludlam The treatment of bleeding in acquired haemophilia with recombinant factor VIIa Thromb. Haemost. 78 1997 1463 1467
-
(1997)
Thromb. Haemost.
, vol.78
, pp. 1463-1467
-
-
Hay, C.R.M.1
Negrier, C.2
Ludlam, C.A.3
-
19
-
-
0025477245
-
Factor VII in the treatment of haemophilia
-
U. Hedner Factor VII in the treatment of haemophilia Blood Coagul. Fibrinolysis 1 1990 307 317
-
(1990)
Blood Coagul. Fibrinolysis
, vol.1
, pp. 307-317
-
-
Hedner, U.1
-
20
-
-
0027522777
-
Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders
-
U. Hedner, S. Glazer, and J. Falch Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders Transfus. Med. Rev. 7 1993 78 83
-
(1993)
Transfus. Med. Rev.
, vol.7
, pp. 78-83
-
-
Hedner, U.1
Glazer, S.2
Falch, J.3
-
21
-
-
0027236665
-
Safety and initial efficacy of three dose-levels of recombinant activated factor VII (rVIIa): Results of a phase I study
-
B.G. Macik, C.M. Lindley, J. Lusher, W.T. Sawyer, A.L. Bloom, and J.F. Harrison Safety and initial efficacy of three dose-levels of recombinant activated factor VII (rVIIa): results of a phase I study Blood Coagul. Fibrinolysis 4 1993 521 527
-
(1993)
Blood Coagul. Fibrinolysis
, vol.4
, pp. 521-527
-
-
MacIk, B.G.1
Lindley, C.M.2
Lusher, J.3
Sawyer, W.T.4
Bloom, A.L.5
Harrison, J.F.6
|